Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

novolimus

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
  • H. Nef, J. Wiebe, +10 authors C. Hamm
  • Catheterization and cardiovascular interventions…
  • 2018
  • Corpus ID: 3670644
To date, experience with bioresorbable scaffolds (BRS) that elute agents other than everolimus is limited. Thus, a post‐marketing… Expand
Review
2017
Review
2017
The DESolve® scaffold (Elixir Medical Corporation, Sunnyvale, California, USA) is manufactured from a poly-l-lactide based… Expand
2017
2017
OBJECTIVES The purpose of this study was to compare the 1-year outcome of everolimus-eluting bioresorbable scaffolds (eBRS) and… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2016
Highly Cited
2016
OBJECTIVES This study sought to report the late multimodality imaging and clinical outcomes of the novel poly-l-lactic-acid-based… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2016
2016
AIMS Newer-generation drug-eluting stents (DES) have been shown to be superior to first-generation DES. Current-generation DES… Expand
Review
2016
Review
2016
  • A. Dalal
  • World journal of transplantation
  • 2016
  • Corpus ID: 15813515
Patients listed for organ transplant frequently have severe coronary artery disease (CAD), which may be treated with drug eluting… Expand
  • table 1
  • table 2
2010
2010
AIMS Novolimus, a macrocyclic lactone with anti-proliferative properties, has a similar efficacy to currently available agents… Expand
2010
2010
textabstractAims: Novolimus, a macrocyclic lactone with anti-proliferative properties, has a similar efficacy to currently… Expand
2010
2010
Owing to their marked efficacy in reducing restenosis, drug-eluting stents currently represent the predominant strategy for… Expand
  • figure 1
  • table 1
  • figure 2
2008
2008
AIMS First generation DES have markedly reduced restenosis. However, there is a major interest in developing new DES with greater… Expand